ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VANESSA GREENIER MD

Internal Medicine

6,289

$280K

325
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

ANGELO PHARMAKIDIS M.D.,PH.D

Internal Medicine

6,288

$280K

143
124 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

GEOFFREY HAMILTON MD

Internal Medicine

6,220

$259K

457
372 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

IWONA PAOLUCCI M.D.

Internal Medicine

6,210

$282K

277
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

SADIA IFTIKHAR MD

Internal Medicine

6,133

$257K

266
206 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

LAURA OFSTEAD MD

Internal Medicine

6,127

$337K

289
246 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

DANIEL HOCHBERGER M.D.

Internal Medicine

6,111

$550K

274
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $51

DANIELA TURACOVA M.D.

Internal Medicine

6,091

$297K

384
249 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

JAVID CALCATTI MD

Internal Medicine

6,034

$224K

264
219 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

WILLIAM MASON M.D.

Internal Medicine

6,028

$340K

344
252 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

RICHARD TURNER MD

Internal Medicine

5,925

$317K

235
223 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

SUMAIRA ALI M.D.

Internal Medicine

5,904

$308K

331
270 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

VITO LONGOBARDI M.D.

Internal Medicine

5,892

$398K

311
238 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $51

ZSOLT ORBAN MD

Internal Medicine

5,874

$282K

421
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $51

TIMOTHY O'MARA M.D.

Internal Medicine

5,847

$300K

396
307 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

JAMES SULLIVAN MD

Internal Medicine

5,830

$201K

347
282 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $51

JAMES ROSS MD

Internal Medicine

5,814

$235K

415
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

KATHLEEN HENDERSON M.D.

Internal Medicine

5,812

$257K

273
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

ROBERT ELLISON M.D.

Internal Medicine

5,794

$277K

379
317 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $51

DIANE SIEDLECKI M.D.

Internal Medicine

5,791

$414K

302
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $51

USHA PANNEERSELVAM MD

Internal Medicine

5,756

$231K

216
190 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

HAROLD SANDERS MD

Internal Medicine

5,702

$287K

311
248 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

RINCHEN-TZO EMGUSHOV MD

Internal Medicine

5,684

$787K

228
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$138
Average prescription price

Avg: $51

SAPNA CHOWDHRY MD

Internal Medicine

5,656

$770K

194
57 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $51

OMAR MEER M.D.

Internal Medicine

5,612

$224K

219
148 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank